
Canada • Toronto Stock Exchange • TSX:CRH
The current stock price of CRH.CA is 4.99 null. In the past month the price increased by 1.01%. In the past year, price increased by 78.21%.
ChartMill assigns a technical rating of 8 / 10 to CRH.CA. When comparing the yearly performance of all stocks, CRH.CA is one of the better performing stocks in the market, outperforming 78.83% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to CRH.CA. CRH.CA has only an average score on both its financial health and profitability.
Over the last trailing twelve months CRH.CA reported a non-GAAP Earnings per Share(EPS) of -0.342. The EPS decreased by -757.69% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -23.05% | ||
| ROA | -12.76% | ||
| ROE | N/A | ||
| Debt/Equity | 1.31 |
CRH Medical Corp provides anesthesiology services to gastroenterologists in the United States through its subsidiaries and also specializes in the treatment of hemorrhoids utilizing its treatment protocol and patented proprietary technology.
CRH Medical Corp
999 Canada Place
Vancouver BC V6C 3E1
CEO: Tushar M. Ramani
Phone: +1 425 658-0151
CRH Medical Corp provides anesthesiology services to gastroenterologists in the United States through its subsidiaries and also specializes in the treatment of hemorrhoids utilizing its treatment protocol and patented proprietary technology.
The current stock price of CRH.CA is 4.99 null. The price increased by 0.4% in the last trading session.
CRH.CA does not pay a dividend.
CRH.CA has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
CRH.CA stock is listed on the Toronto Stock Exchange exchange.
CRH Medical Corp (CRH.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.34).
CRH Medical Corp (CRH.CA) has a market capitalization of 357.38M null. This makes CRH.CA a Small Cap stock.